Zimmer Biomet - Any whispers about restructuring in R&D?

Hey everyone, been feeling a bit uneasy lately. Not seeing any concrete news, but there's this general hum of 'potential changes' circulating, especially within the R&D departments. Anyone else picking up on this? Feels like they might be looking to streamline or consolidate some of the innovation pipelines. Haven't heard of any official announcements, but the grapevine is pretty active. Wondering if anyone has insights into specific areas or teams that might be affected. Trying to gauge if this is just general market anxiety or if there's something more specific happening at ZB. Just want to be prepared, you know? Any intel would be appreciated.